Cardiovascular concentration–effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studies

MLA

Chotsiri, P., et al. “Cardiovascular Concentration–effect Relationships of Amodiaquine and Its Metabolite Desethylamodiaquine: Clinical and Preclinical Studies.” British Journal of Clinical Pharmacology, vol. 89, Nov. 2022, pp. 1176–86. EBSCOhost, https://doi.org/10.1111/bcp.15569.

APA

Chotsiri, P., Chan, X., Capel, R., Pike, J., Hanboonkunupakarn, B., Lee, S., Hanafiah, M., Win, Y., Cremer, M., Kiechel, J., Ogutu, B., Taylor, W., Burton, R., Tarning, J., & White, N. (2022). Cardiovascular concentration–effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studies. British Journal of Clinical Pharmacology, 89, 1176–1186. https://doi.org/10.1111/bcp.15569

Chicago

Chotsiri, P, Xhs Chan, Ra Capel, J Pike, B Hanboonkunupakarn, Sj Lee, M Hanafiah, et al. 2022. “Cardiovascular Concentration–effect Relationships of Amodiaquine and Its Metabolite Desethylamodiaquine: Clinical and Preclinical Studies.” British Journal of Clinical Pharmacology 89 (November): 1176–86. doi:10.1111/bcp.15569.